The value of transesophageal echocardiography in the investigation and management of cryptogenic cerebral ischemia: a single-center experience
Jazyk angličtina Země Itálie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26705252
DOI
10.1007/s10072-015-2448-y
PII: 10.1007/s10072-015-2448-y
Knihovny.cz E-zdroje
- Klíčová slova
- Anticoagulation, Aorta atheromatosis, Cryptogenic stroke, Patent foramen ovale, Transesophageal echocardiography,
- MeSH
- aterosklerotický plát diagnostické zobrazování epidemiologie MeSH
- cévní mozková příhoda diagnostické zobrazování epidemiologie prevence a kontrola MeSH
- echokardiografie transezofageální * MeSH
- foramen ovale apertum diagnostické zobrazování epidemiologie MeSH
- ischemie mozku diagnostické zobrazování epidemiologie prevence a kontrola MeSH
- lidé středního věku MeSH
- lidé MeSH
- lineární modely MeSH
- nemoci aorty diagnostické zobrazování epidemiologie MeSH
- pohlavní dimorfismus MeSH
- prevalence MeSH
- retrospektivní studie MeSH
- sekundární prevence MeSH
- věkové faktory MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The diagnostic utility of transesophageal echocardiography (TEE) has often been challenged in patients with cryptogenic stroke (CS). We estimated the prevalence of different findings on TEE examination of CS patients, their impact on secondary stroke prevention and the presence of potential age or gender disparities. We reviewed all TEE examinations that were performed in a single echocardiography laboratory during a 7-year-old period to identify CS patients that underwent investigation with TEE. Of the 518 total TEE examinations, we identified 88 CS patients. TEE revealed abnormal findings in 69.3 % of them. Patent foramen ovale (PFO) and atrial septal aneurysm (ASA) were identified in 30.6 and 22.7 % of the patients. Ascending aorta and aortic arch atheromatosis was present in 26.1 % of the patients, with complex atheromatosis diagnosed in 14.7 % of them. Cardiac myxomas were uncovered in 2.3 %. Thrombi in the left atrium and in cardiac valves were reported in 3.4 and 2.3 % of the patients, respectively. Based on TEE findings, the therapeutic management would be very likely modified in 9.1 % of the patients. Subgroup analysis revealed no gender disparities on the prevalence of TEE findings and in secondary stroke prevention, while linear regression analyses revealed significant associations of age with the prevalence of PFO, ASA, aorta atheromatosis and complex aorta atheromatosis. TEE examination should be included in the diagnostic work-up of all CS patients, irrespective of age and gender status, since it can reveal potential sources of embolism and has a significant impact for secondary stroke prevention.
1st Division of Internal Medicine University of Ioannina School of Medicine Ioannina Greece
Department of Cardiology Hatzikosta General Hospital Ioannina Greece
Department of Neurology University of Tennessee Health Science Center Memphis TN USA
Division of Gastroenterology University of Ioannina School of Medicine Ioannina Greece
International Clinical Research Center St Anne's University Hospital in Brno Brno Czech Republic
Neurosurgical Research Institute University of Ioannina Ioannina Greece
Zobrazit více v PubMed
Stroke. 1993 Jan;24(1):35-41 PubMed
Am J Cardiol. 1997 Aug 28;80(4C):19D-28D; discussion 35D-39D PubMed
Eur Heart J. 1993 Sep;14 (9):1223-8 PubMed
Echocardiography. 2005 Oct;22(9):770-4 PubMed
Eur J Neurol. 2016 Mar;23 (3):569-79 PubMed
Stroke. 2014 Nov;45(11):3352-9 PubMed
Eur J Echocardiogr. 2010 Aug;11(7):557-76 PubMed
Stroke. 2009 Aug;40(8):2893-8 PubMed
Stroke. 2014 Jul;45(7):2160-236 PubMed
Stroke. 1995 Oct;26(10 ):1820-4 PubMed